pillbase.ru

Biktarvy

Active substance: BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE

TABLET · BICTEGRAVIR SODIUM 30 mg/1, EMTRICITABINE 120 mg/1, TENOFOVIR ALAFENAMIDE FUMARATE 15 mg/1

United StatesActive

Marketing holder: Gilead Sciences, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing bictegravir in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 2
  • Биктарви®
    таблетки, покрытые пленочной оболочкой, 50 мг+25 мг+200 мг (original in Russian, GRLS)
    ЛП-№(006098)-(РГ-RU)
    Гилеад Сайенсиз Интернешнл Лтд.
  • Биктарви®
    таблетки, покрытые пленочной оболочкой, 50 мг+25 мг+200 мг (original in Russian, GRLS)
    ЛП-006054
    Гилеад Сайенсиз Интернешнл Лимитед
EU 1
  • Biktarvy
    bictegravir, emtricitabine, tenofovir alafenamide, fumarate
    EMEA/H/C/004449
    Gilead Sciences Ireland UC
Registration
Registration number
61958-2506
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 61958-2506 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 61958-2506 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 61958-2506 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 61958-2506 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 61958-2506 · Verified 2026-10-09 · open in source